These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

837 related articles for article (PubMed ID: 16339681)

  • 1. Transfusion safety: Where are we today?
    Luban NL
    Ann N Y Acad Sci; 2005; 1054():325-41. PubMed ID: 16339681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current risks in blood transfusion in Japan.
    Otsubo H; Yamaguchi K
    Jpn J Infect Dis; 2008 Nov; 61(6):427-33. PubMed ID: 19050347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New technologies for the inactivation of infectious pathogens in cellular blood components and the development of platelet substitutes.
    Corash L
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):549-63. PubMed ID: 11102276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion-transmitted infections: existing and emerging pathogens.
    Kaur P; Basu S
    J Postgrad Med; 2005; 51(2):146-51. PubMed ID: 16006714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reengineering transfusion and cellular therapy processes hospitalwide: ensuring the safe utilization of blood products.
    Brooks JP
    Transfusion; 2005 Oct; 45(4 Suppl):159S-71S. PubMed ID: 16181401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing emerging infectious threats to blood safety for the blood disorders community.
    Trimble SR; Parker CS; Grant AM; Soucie JM; Reyes N
    Am J Prev Med; 2010 Apr; 38(4 Suppl):S468-74. PubMed ID: 20331945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of the blood-borne viruses: blood banking and transfusion medicine.
    Sherwood WC
    Dev Biol Stand; 1993; 81():25-33. PubMed ID: 8174810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress toward a pathogen-free blood supply.
    McCullough J
    Clin Infect Dis; 2003 Jul; 37(1):88-95. PubMed ID: 12830413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reacting to an emerging safety threat: West Nile virus in North America.
    Stramer SL
    Dev Biol (Basel); 2007; 127():43-58. PubMed ID: 17486880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.
    Blajchman MA
    Transfus Clin Biol; 2009 May; 16(2):70-4. PubMed ID: 19427252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectious risks of blood transfusion.
    Uhl L
    Curr Hematol Rep; 2002 Nov; 1(2):156-62. PubMed ID: 12901138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of West Nile virus safety policies by Canadian blood services: guiding principles and a comparison between Canada and the United States.
    Vamvakas EC; Kleinman S; Hume H; Sher GD
    Transfus Med Rev; 2006 Apr; 20(2):97-109. PubMed ID: 16565024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion.
    Kleinman SH; Glynn SA; Higgins MJ; Triulzi DJ; Smith JW; Nass CC; Garratty G; Murphy EL; LeParc GF; Schreiber GB; King MR; Chamberland ME; Nemo GJ
    Transfusion; 2005 Jul; 45(7):1073-83. PubMed ID: 15987350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative strategies in assuring blood safety: An overview.
    Epstein JS
    Biologicals; 2010 Jan; 38(1):31-5. PubMed ID: 20110174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European strategies against the parasite transfusion risk.
    Reesink HW
    Transfus Clin Biol; 2005 Feb; 12(1):1-4. PubMed ID: 15814284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion-transmitted infections.
    Bihl F; Castelli D; Marincola F; Dodd RY; Brander C
    J Transl Med; 2007 Jun; 5():25. PubMed ID: 17553144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of the blood supply.
    Sloand EM; Pitt E; Klein HG
    JAMA; 1995 Nov; 274(17):1368-73. PubMed ID: 7563562
    [No Abstract]   [Full Text] [Related]  

  • 18. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches to minimize infection risk in blood banking and transfusion practice.
    Lindholm PF; Annen K; Ramsey G
    Infect Disord Drug Targets; 2011 Feb; 11(1):45-56. PubMed ID: 21303341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection criteria to protect the blood donor in North America and Europe: past (dogma), present (evidence), and future (hemovigilance).
    Eder A; Goldman M; Rossmann S; Waxman D; Bianco C
    Transfus Med Rev; 2009 Jul; 23(3):205-20. PubMed ID: 19539875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.